Skip to content

Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical Length

Randomised Controlled Trial Comparing Vaginal Pessary and Progestogen as an Intervention in Twin Pregnancy With Short Cervical Length to Prevent Spontaneous Preterm Birth

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04342585
Enrollment
142
Registered
2020-04-13
Start date
2019-10-01
Completion date
2022-09-30
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Keywords

twin, vaginal pessary, vaginal progestogen, short cervix

Brief summary

A randomized clinical trial comparing vaginal progestogen and vaginal pessary as an intervention for twin pregnancies with short cervical length.

Detailed description

This is a randomized controlled trial to compare women with twin pregnancies and diagnosed with asymptomatic short cervical length. Two types of interventions will be compared i.e vaginal progestogen and vaginal pessary.

Interventions

DRUGMicronised vaginal progesterone

A diary will be given to participants to ensure compliance.

The internal diameter size will be decided based on the clinical assessment of the cervix.

Sponsors

National University of Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

All women with twin pregnancies will be screened for suitability via measurement of the cervical length at 20 to 24 weeks gestation. Those with a cervical length of 30mm or less will be recruited into the study.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* all twin pregnancies * cervical length less than 30mm

Exclusion criteria

* Twin to twin transfusion syndrome * Stillbirth * congenital anomaly in one of the fetuses * previous cervical trauma or surgery * cervical cerclage in current pregnancy * premature labour with or without rupture of membranes * severe vaginal discharge * acute vaginitis or cervicitis

Design outcomes

Primary

MeasureTime frameDescription
Spontaneous preterm birthThrough study completion up to 37 weeksMean gestational age at delivery in weeks

Secondary

MeasureTime frameDescription
RacePre-interventionPercentage of each race recruited
Maternal body mass indexPre-interventionMean maternal body mass index in kg/m2 before pregnancy or in the first trimester
ParityPre-interventionMean number of parity
Type of twin pregnancyPre-interventionChorionicity of twin pregnancy
Type of conceptionPre-interventionMethod of conception
Gestational age at recruitmentPre-interventionMean gestational age at recruitment in weeks
Gestational age at commencement of treatmentPre-interventionMean gestational age at commencement of treatment in weeks
Cervical length before commencement of treatmentPre-interventionMean cervical length before commencement of treatment in mm
Vaginal infectionPre-interventionPercentage of participants with vaginal infection prior to commencement of treatment
Previous miscarriagesPre-interventionPercentage of participants with previous first and second trimester miscarriages
Pre-existing medical disordersPre-interventionPercentage of participants with pre-existing medical disorders
Previous spontaneous preterm birthPre-interventionPercentage of participants with previous spontaneous preterm birth
Maternal agePre-interventionMean maternal age in years
Fetal complicationsThrough study completion up to 37 weeksPercentage of participants with fetal complications
Mode of deliveryThrough study completion up to 37 weeksPercentage of participants who delivered vaginally or via caesarean section
Intrapartum complicationsThroughout labour up to delivery of the neonatePercentage of participants with intrapartum complications
Postpartum complicationsThrough delivery of neonate up to 42 days after deliveryPercentage of participants with postpartum complications
Total blood lossThrough delivery of neonate up to 42 days after deliveryMean total blood loss in ml
Birth weightImmediately after birth of neonateMean birth weight in grams
Apgar scoreImmediately after birth of neonateMean Apgar score
Anthropometry assessment of neonatesImmediately after birth of neonateMean length and head circumference of neonates at birth in cm
Neonatal intensive care unit admissionImmediately after birth of neonate up to discharge (approximately 30 days)Percentage of neonates required Neonatal intensive care unit admission
Duration in neonatal intensive care unitThrough neonatal intensive care unit stay up to discharge (approximately 30 days)Mean duration in neonatal intensive care unit in days
Neonatal complicationsImmediately after birth up to 30 daysPercentage of neonates with complications
Antenatal complicationsThrough study completion up to 37 weeksPercentage of participants with antenatal complications

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026